596 results on '"Wood, Matthew D."'
Search Results
2. Content Validation of the Behavioral and Emotional Rating Scale--3rd Edition: Strength-Based Interview
- Author
-
Pierce, Corey D., Epstein, Michael H., and Wood, Matthew D.
- Abstract
Strength-based assessment has achieved acceptance from educational, mental health, and social service professionals as a means to measuring emotional and behavioral strengths of children. Several standardized, norm-referenced tests have been developed to assess these strengths; however, the primary mode of assessment is via informal interviews of parents and caregivers. In many cases, these interviews lack psychometric support, including basic validity and reliability. The purpose of this study was to document the multistep process used to establish the content validity of a newly developed instrument: Behavioral and Emotional Rating Scale: Strength-Based Interview. Specifically, the results of a survey of 40 U.S. professional mental health staff and educators are described where respondents rated the importance of interview questions to the construct of strength-based assessment. The findings of the survey as well as the 18 items deemed most important are reported. Research limitations, future research, and implications for mental health and educational professionals are discussed.
- Published
- 2023
- Full Text
- View/download PDF
3. The children's brain tumor network (CBTN) - Accelerating research in pediatric central nervous system tumors through collaboration and open science
- Author
-
Lilly, Jena V, Rokita, Jo Lynne, Mason, Jennifer L, Patton, Tatiana, Stefankiewiz, Stephanie, Higgins, David, Trooskin, Gerri, Larouci, Carina A, Arya, Kamnaa, Appert, Elizabeth, Heath, Allison P, Zhu, Yuankun, Brown, Miguel A, Zhang, Bo, Farrow, Bailey K, Robins, Shannon, Morgan, Allison M, Nguyen, Thinh Q, Frenkel, Elizabeth, Lehmann, Kaitlin, Drake, Emily, Sullivan, Catherine, Plisiewicz, Alexa, Coleman, Noel, Patterson, Luke, Koptyra, Mateusz, Helili, Zeinab, Van Kuren, Nicholas, Young, Nathan, Kim, Meen Chul, Friedman, Christopher, Lubneuski, Alex, Blackden, Christopher, Williams, Marti, Baubet, Valerie, Tauhid, Lamiya, Galanaugh, Jamie, Boucher, Katie, Ijaz, Heba, Cole, Kristina A, Choudhari, Namrata, Santi, Mariarita, Moulder, Robert W, Waller, Jonathan, Rife, Whitney, Diskin, Sharon J, Mateos, Marion, Parsons, Donald W, Pollack, Ian F, Goldman, Stewart, Leary, Sarah, Caporalini, Chiara, Buccoliero, Anna Maria, Scagnet, Mirko, Haussler, David, Hanson, Derek, Firestein, Ron, Cain, Jason, Phillips, Joanna J, Gupta, Nalin, Mueller, Sabine, Grant, Gerald, Monje-Deisseroth, Michelle, Partap, Sonia, Greenfield, Jeffrey P, Hashizume, Rintaro, Smith, Amy, Zhu, Shida, Johnston, James M, Fangusaro, Jason R, Miller, Matthew, Wood, Matthew D, Gardner, Sharon, Carter, Claire L, Prolo, Laura M, Pisapia, Jared, Pehlivan, Katherine, Franson, Andrea, Niazi, Toba, Rubin, Josh, Abdelbaki, Mohamed, Ziegler, David S, Lindsay, Holly B, Stucklin, Ana Guerreiro, Gerber, Nicolas, Vaske, Olena M, Quinsey, Carolyn, Rood, Brian R, Nazarian, Javad, Raabe, Eric, Jackson, Eric M, Stapleton, Stacie, Lober, Robert M, Kram, David E, Koschmann, Carl, Storm, Phillip B, Lulla, Rishi R, Prados, Michael, Resnick, Adam C, and Waanders, Angela J
- Subjects
Neurosciences ,Pediatric Cancer ,Brain Disorders ,Pediatric Research Initiative ,Pediatric ,Brain Cancer ,Rare Diseases ,Cancer ,Good Health and Well Being ,Adult ,Humans ,Child ,Quality of Life ,Brain Neoplasms ,Collaborative international research infrastructure ,Pediatric brain tumors ,Multi-omic data ,Longitudinal clinical data ,Biospecimens ,Molecular clinical trials ,Clinical Sciences ,Oncology & Carcinogenesis - Abstract
Pediatric brain tumors are the leading cause of cancer-related death in children in the United States and contribute a disproportionate number of potential years of life lost compared to adult cancers. Moreover, survivors frequently suffer long-term side effects, including secondary cancers. The Children's Brain Tumor Network (CBTN) is a multi-institutional international clinical research consortium created to advance therapeutic development through the collection and rapid distribution of biospecimens and data via open-science research platforms for real-time access and use by the global research community. The CBTN's 32 member institutions utilize a shared regulatory governance architecture at the Children's Hospital of Philadelphia to accelerate and maximize the use of biospecimens and data. As of August 2022, CBTN has enrolled over 4700 subjects, over 1500 parents, and collected over 65,000 biospecimen aliquots for research. Additionally, over 80 preclinical models have been developed from collected tumors. Multi-omic data for over 1000 tumors and germline material are currently available with data generation for > 5000 samples underway. To our knowledge, CBTN provides the largest open-access pediatric brain tumor multi-omic dataset annotated with longitudinal clinical and outcome data, imaging, associated biospecimens, child-parent genomic pedigrees, and in vivo and in vitro preclinical models. Empowered by NIH-supported platforms such as the Kids First Data Resource and the Childhood Cancer Data Initiative, the CBTN continues to expand the resources needed for scientists to accelerate translational impact for improved outcomes and quality of life for children with brain and spinal cord tumors.
- Published
- 2023
4. Interpretation of Data from Translational Rodent Nerve Injury and Repair Models
- Author
-
Marsh, Evan B., Snyder-Warwick, Alison K., Mackinnon, Susan E., and Wood, Matthew D.
- Published
- 2024
- Full Text
- View/download PDF
5. SP56. Effects Of Systemic T Cell Modulation On Nerve Regeneration After Segmental Injury
- Author
-
Pinni, Sai L., Finnan, Michael J., Schellhardt, Lauren, Snyder-Warwick, Alison K., Mackinnon, Susan E., and Wood, Matthew D.
- Published
- 2024
- Full Text
- View/download PDF
6. Molecular profiling of pre- and post-treatment pediatric high-grade astrocytomas reveals acquired increased tumor mutation burden in a subset of recurrences
- Author
-
Wood, Matthew D., Beadling, Carol, Neff, Tanaya, Moore, Steve, Harrington, Christina A., Baird, Lissa, and Corless, Christopher
- Published
- 2023
- Full Text
- View/download PDF
7. Glioblastomas with primitive neuronal component harbor a distinct methylation and copy-number profile with inactivation of TP53, PTEN, and RB1
- Author
-
Suwala, Abigail K, Stichel, Damian, Schrimpf, Daniel, Maas, Sybren LN, Sill, Martin, Dohmen, Hildegard, Banan, Rouzbeh, Reinhardt, Annekathrin, Sievers, Philipp, Hinz, Felix, Blattner-Johnson, Mirjam, Hartmann, Christian, Schweizer, Leonille, Boldt, Henning B, Kristensen, Bjarne Winther, Schittenhelm, Jens, Wood, Matthew D, Chotard, Guillaume, Bjergvig, Rolf, Das, Anirban, Tabori, Uri, Hasselblatt, Martin, Korshunov, Andrey, Abdullaev, Zied, Quezado, Martha, Aldape, Kenneth, Harter, Patrick N, Snuderl, Matija, Hench, Jürgen, Frank, Stephan, Acker, Till, Brandner, Sebastian, Winkler, Frank, Wesseling, Pieter, Pfister, Stefan M, Reuss, David E, Wick, Wolfgang, von Deimling, Andreas, Jones, David TW, and Sahm, Felix
- Subjects
Biomedical and Clinical Sciences ,Clinical Sciences ,Oncology and Carcinogenesis ,Brain Disorders ,Human Genome ,Brain Cancer ,Neurosciences ,Cancer ,Rare Diseases ,Genetics ,2.1 Biological and endogenous factors ,Aetiology ,Brain Neoplasms ,Chromosomes ,Human ,Pair 1 ,Chromosomes ,Human ,Pair 7 ,Cohort Studies ,Cyclin-Dependent Kinase Inhibitor p16 ,DNA Copy Number Variations ,DNA Methylation ,Female ,Gene Deletion ,Glial Fibrillary Acidic Protein ,Glioblastoma ,Humans ,Male ,Middle Aged ,Neuroectodermal Tumors ,Primitive ,PTEN Phosphohydrolase ,Retinoblastoma Binding Proteins ,Tumor Suppressor Protein p53 ,Ubiquitin-Protein Ligases ,GBM ,PNET ,DNA methylation ,Phenotype ,Classification ,Plasticity ,Neurology & Neurosurgery - Abstract
Glioblastoma IDH-wildtype presents with a wide histological spectrum. Some features are so distinctive that they are considered as separate histological variants or patterns for the purpose of classification. However, these usually lack defined (epi-)genetic alterations or profiles correlating with this histology. Here, we describe a molecular subtype with overlap to the unique histological pattern of glioblastoma with primitive neuronal component. Our cohort consists of 63 IDH-wildtype glioblastomas that harbor a characteristic DNA methylation profile. Median age at diagnosis was 59.5 years. Copy-number variations and genetic sequencing revealed frequent alterations in TP53, RB1 and PTEN, with fewer gains of chromosome 7 and homozygous CDKN2A/B deletions than usually described for IDH-wildtype glioblastoma. Gains of chromosome 1 were detected in more than half of the cases. A poorly differentiated phenotype with frequent absence of GFAP expression, high proliferation index and strong staining for p53 and TTF1 often caused misleading histological classification as carcinoma metastasis or primitive neuroectodermal tumor. Clinically, many patients presented with leptomeningeal dissemination and spinal metastasis. Outcome was poor with a median overall survival of only 12 months. Overall, we describe a new molecular subtype of IDH-wildtype glioblastoma with a distinct histological appearance and genetic signature.
- Published
- 2021
8. Comprehensive analysis of diverse low-grade neuroepithelial tumors with FGFR1 alterations reveals a distinct molecular signature of rosette-forming glioneuronal tumor
- Author
-
Lucas, Calixto-Hope G, Gupta, Rohit, Doo, Pamela, Lee, Julieann C, Cadwell, Cathryn R, Ramani, Biswarathan, Hofmann, Jeffrey W, Sloan, Emily A, Kleinschmidt-DeMasters, Bette K, Lee, Han S, Wood, Matthew D, Grafe, Marjorie, Born, Donald, Vogel, Hannes, Salamat, Shahriar, Puccetti, Diane, Scharnhorst, David, Samuel, David, Cooney, Tabitha, Cham, Elaine, Jin, Lee-way, Khatib, Ziad, Maher, Ossama, Chamyan, Gabriel, Brathwaite, Carole, Bannykh, Serguei, Mueller, Sabine, Kline, Cassie N, Banerjee, Anu, Reddy, Alyssa, Taylor, Jennie W, Clarke, Jennifer L, Oberheim Bush, Nancy Ann, Butowski, Nicholas, Gupta, Nalin, Auguste, Kurtis I, Sun, Peter P, Roland, Jarod L, Raffel, Corey, Aghi, Manish K, Theodosopoulos, Philip, Chang, Edward, Hervey-Jumper, Shawn, Phillips, Joanna J, Pekmezci, Melike, Bollen, Andrew W, Tihan, Tarik, Chang, Susan, Berger, Mitchel S, Perry, Arie, and Solomon, David A
- Subjects
Biological Sciences ,Biomedical and Clinical Sciences ,Clinical Sciences ,Oncology and Carcinogenesis ,Cancer ,Rare Diseases ,Genetics ,Human Genome ,Aetiology ,2.1 Biological and endogenous factors ,Adolescent ,Adult ,Aged ,Brain Neoplasms ,Child ,Female ,Humans ,Male ,Middle Aged ,Mutation ,Neoplasms ,Neuroepithelial ,Receptor ,Fibroblast Growth Factor ,Type 1 ,Spinal Cord Neoplasms ,Young Adult ,Rosette-forming glioneuronal tumor ,Extraventricular neurocytoma ,Dysembryoplastic neuroepithelial tumor ,Pilocytic astrocytoma ,FGFR1 ,PIK3CA ,Molecular neuropathology ,DNA methylation profiling ,PIK3R1 ,Biochemistry and Cell Biology ,Neurosciences ,Biochemistry and cell biology - Abstract
The FGFR1 gene encoding fibroblast growth factor receptor 1 has emerged as a frequently altered oncogene in the pathogenesis of multiple low-grade neuroepithelial tumor (LGNET) subtypes including pilocytic astrocytoma, dysembryoplastic neuroepithelial tumor (DNT), rosette-forming glioneuronal tumor (RGNT), and extraventricular neurocytoma (EVN). These activating FGFR1 alterations in LGNET can include tandem duplication of the exons encoding the intracellular tyrosine kinase domain, in-frame gene fusions most often with TACC1 as the partner, or hotspot missense mutations within the tyrosine kinase domain (either at p.N546 or p.K656). However, the specificity of these different FGFR1 events for the various LGNET subtypes and accompanying genetic alterations are not well defined. Here we performed comprehensive genomic and epigenomic characterization on a diverse cohort of 30 LGNET with FGFR1 alterations. We identified that RGNT harbors a distinct epigenetic signature compared to other LGNET with FGFR1 alterations, and is uniquely characterized by FGFR1 kinase domain hotspot missense mutations in combination with either PIK3CA or PIK3R1 mutation, often with accompanying NF1 or PTPN11 mutation. In contrast, EVN harbors its own distinct epigenetic signature and is characterized by FGFR1-TACC1 fusion as the solitary pathogenic alteration. Additionally, DNT and pilocytic astrocytoma are characterized by either kinase domain tandem duplication or hotspot missense mutations, occasionally with accompanying NF1 or PTPN11 mutation, but lacking the accompanying PIK3CA or PIK3R1 mutation that characterizes RGNT. The glial component of LGNET with FGFR1 alterations typically has a predominantly oligodendroglial morphology, and many of the pilocytic astrocytomas with FGFR1 alterations lack the biphasic pattern, piloid processes, and Rosenthal fibers that characterize pilocytic astrocytomas with BRAF mutation or fusion. Together, this analysis improves the classification and histopathologic stratification of LGNET with FGFR1 alterations.
- Published
- 2020
9. Balancing risk and trust for strategic alliance formation decisions
- Author
-
Collier, Zachary A., Wood, Matthew D., and Henderson, Dale A.
- Published
- 2022
- Full Text
- View/download PDF
10. An unusual recurrent high-grade glioneuronal tumor with MAP2K1 mutation and CDKN2A/B homozygous deletion
- Author
-
Cheaney, Barry, Bowden, Stephen, Krause, Katie, Sloan, Emily A, Perry, Arie, Solomon, David A, Han, Seunggu Jude, and Wood, Matthew D
- Subjects
Biomedical and Clinical Sciences ,Oncology and Carcinogenesis ,Aged ,Brain Neoplasms ,Cyclin-Dependent Kinase Inhibitor p15 ,Cyclin-Dependent Kinase Inhibitor p16 ,Ganglioglioma ,Gene Deletion ,Homozygote ,Humans ,MAP Kinase Kinase 1 ,Male ,Mutation ,Neoplasm Grading ,Neoplasm Recurrence ,Local ,Glioneuronal tumor ,Anaplastic ,MAP2K1 mutation ,CDKN2A ,B homozygous deletion ,Multinodular and vacuolating neuronal tumor of the cerebrum ,Next-generation sequencing ,CDKN2A/B homozygous deletion ,Biochemistry and Cell Biology ,Clinical Sciences ,Neurosciences ,Biochemistry and cell biology - Published
- 2019
11. A case of recurrent epilepsy‐associated rosette‐forming glioneuronal tumor with anaplastic transformation in the absence of therapy
- Author
-
Halfpenny, Aaron, Ferris, Sean P, Grafe, Marjorie, Woltjer, Randy, Selden, Nathan, Nazemi, Kellie, Perry, Arie, Solomon, David A, Gultekin, Sakir H, Moore, Stephen, Olson, Susan, Lawce, Helen, Lucas, Lora, Corless, Christopher L, and Wood, Matthew D
- Subjects
Biomedical and Clinical Sciences ,Clinical Sciences ,Oncology and Carcinogenesis ,Neurosciences ,Clinical Research ,Cancer ,Neurodegenerative ,Genetics ,Brain Disorders ,Epilepsy ,Rare Diseases ,Aetiology ,2.1 Biological and endogenous factors ,Brain Neoplasms ,Cell Transformation ,Neoplastic ,Child ,Preschool ,Female ,Humans ,Mutation ,Neoplasm Recurrence ,Local ,Neoplasms ,Neuroepithelial ,Temporal Lobe ,X-linked Nuclear Protein ,1p ,19q-codeletion ,anaplastic transformation ,ATRX ,fibroblast growth factor receptor receptor 1 (FGFR1) kinase domain internal tandem duplication ,rosette-forming glioneuronal tumor ,1p/19q-codeletion ,Neurology & Neurosurgery ,Clinical sciences ,Biological psychology - Abstract
Rosette-forming glioneuronal tumor (RGNT) most commonly occurs adjacent to the fourth ventricle and therefore rarely presents with epilepsy. Recent reports describe RGNT occurrence in other anatomical locations with considerable morphologic and genetic overlap with the epilepsy-associated dysembryoplastic neuroepithelial tumor (DNET). Examples of RGNT or DNET with anaplastic change are rare, and typically occur in the setting of radiation treatment. We present the case of a 5-year-old girl with seizures, who underwent near total resection of a cystic temporal lobe lesion. Pathology showed morphologic and immunohistochemical features of RGNT, albeit with focally overlapping DNET-like patterns. Resections of residual or recurrent tumor were performed 1 year and 5 years after the initial resection, but no adjuvant radiation or chemotherapy was given. Ten years after the initial resection, surveillance imaging identified new and enhancing nodules, leading to another gross total resection. This specimen showed areas similar to the original tumor, but also high-grade foci with oligodendroglial morphology, increased cellularity, palisading necrosis, microvascular proliferation, and up to 13 mitotic figures per 10 high power fields. Ancillary studies the status by sequencing showed wild-type of the isocitrate dehydrogenase 1 (IDH1), IDH2, and human histone 3.3 (H3F3A) genes, and BRAF studies were negative for mutation or rearrangement. Fluorescence in situ hybridization (FISH) showed codeletion of 1p and 19q limited to the high-grade regions. By immunohistochemistry there was loss of nuclear alpha-thalassemia mental retardation syndrome, X-linked (ATRX) expression only in the high-grade region. Next-generation sequencing showed an fibroblast growth factor receptor receptor 1 (FGFR1) kinase domain internal tandem duplication in three resection specimens. ATRX mutation in the high-grade tumor was confirmed by sequencing which showed a frameshift mutation (p.R1427fs), while the apparent 1p/19q-codeletion by FISH was due to loss of chromosome arm 1p and only partial loss of 19q. Exceptional features of this case include the temporal lobe location, 1p/19q loss by FISH without true whole-arm codeletion, and anaplastic transformation associated with ATRX mutation without radiation or chemotherapy.
- Published
- 2019
12. The children's brain tumor network (CBTN) - Accelerating research in pediatric central nervous system tumors through collaboration and open science
- Author
-
Lilly, Jena V., Rokita, Jo Lynne, Mason, Jennifer L., Patton, Tatiana, Stefankiewiz, Stephanie, Higgins, David, Trooskin, Gerri, Larouci, Carina A., Arya, Kamnaa, Appert, Elizabeth, Heath, Allison P., Zhu, Yuankun, Brown, Miguel A., Zhang, Bo, Farrow, Bailey K., Robins, Shannon, Morgan, Allison M., Nguyen, Thinh Q., Frenkel, Elizabeth, Lehmann, Kaitlin, Drake, Emily, Sullivan, Catherine, Plisiewicz, Alexa, Coleman, Noel, Patterson, Luke, Koptyra, Mateusz, Helili, Zeinab, Van Kuren, Nicholas, Young, Nathan, Kim, Meen Chul, Friedman, Christopher, Lubneuski, Alex, Blackden, Christopher, Williams, Marti, Baubet, Valerie, Tauhid, Lamiya, Galanaugh, Jamie, Boucher, Katie, Ijaz, Heba, Cole, Kristina A., Choudhari, Namrata, Santi, Mariarita, Moulder, Robert W., Waller, Jonathan, Rife, Whitney, Diskin, Sharon J., Mateos, Marion, Parsons, Donald W., Pollack, Ian F., Goldman, Stewart, Leary, Sarah, Caporalini, Chiara, Buccoliero, Anna Maria, Scagnet, Mirko, Haussler, David, Hanson, Derek, Firestein, Ron, Cain, Jason, Phillips, Joanna J., Gupta, Nalin, Mueller, Sabine, Grant, Gerald, Monje-Deisseroth, Michelle, Partap, Sonia, Greenfield, Jeffrey P., Hashizume, Rintaro, Smith, Amy, Zhu, Shida, Johnston, James M., Fangusaro, Jason R., Miller, Matthew, Wood, Matthew D., Gardner, Sharon, Carter, Claire L., Prolo, Laura M., Pisapia, Jared, Pehlivan, Katherine, Franson, Andrea, Niazi, Toba, Rubin, Josh, Abdelbaki, Mohamed, Ziegler, David S., Lindsay, Holly B., Stucklin, Ana Guerreiro, Gerber, Nicolas, Vaske, Olena M., Quinsey, Carolyn, Rood, Brian R., Nazarian, Javad, Raabe, Eric, Jackson, Eric M., Stapleton, Stacie, Lober, Robert M., Kram, David E., Koschmann, Carl, Storm, Phillip B., Lulla, Rishi R., Prados, Michael, Resnick, Adam C., and Waanders, Angela J.
- Published
- 2023
- Full Text
- View/download PDF
13. Limited Nerve Regeneration across Acellular Nerve Allografts (ANAs) Coincides with Changes in Blood Vessel Morphology and the Development of a Pro-Inflammatory Microenvironment
- Author
-
Acevedo Cintrón, Jesús A., primary, Hunter, Daniel A., additional, Schellhardt, Lauren, additional, Pan, Deng, additional, Mackinnon, Susan E., additional, and Wood, Matthew D., additional
- Published
- 2024
- Full Text
- View/download PDF
14. Chemical genetic screens reveal defective lysosomal trafficking as synthetic lethal with NF1 loss.
- Author
-
Bouley, Stephanie J., Grassetti, Andrew V., Allaway, Robert J., Wood, Matthew D., Hou, Helen W., Burdon Dasbach, India R., Seibel, William, Wu, Jimmy, Gerber, Scott A., Dragnev, Konstantin H., Walker, James A., and Sanchez, Yolanda
- Subjects
SCHWANNOMAS ,BREAST ,GENETIC testing ,GENETIC disorders - Abstract
Neurofibromatosis type 1, a genetic disorder caused by pathogenic germline variations in NF1, predisposes individuals to the development of tumors, including cutaneous and plexiform neurofibromas (CNs and PNs), optic gliomas, astrocytomas, juvenile myelomonocytic leukemia, high-grade gliomas and malignant peripheral nerve sheath tumors (MPNSTs), which are chemotherapy- and radiation-resistant sarcomas with poor survival. Loss of NF1 also occurs in sporadic tumors, such as glioblastoma (GBM), melanoma, breast, ovarian and lung cancers. We performed a high-throughput screen for compounds that were synthetic lethal with NF1 loss, which identified several leads, including the small molecule Y102. Treatment of cells with Y102 perturbed autophagy, mitophagy and lysosome positioning in NF1-deficient cells. A dual proteomics approach identified BLOC-one-related complex (BORC), which is required for lysosome positioning and trafficking, as a potential target of Y102. Knockdown of a BORC subunit using siRNA recapitulated the phenotypes observed with Y102 treatment. Our findings demonstrate that BORC might be a promising therapeutic target for NF1-deficient tumors. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
15. Neurofibromin knockdown in glioma cell lines is associated with changes in cytokine and chemokine secretion in vitro.
- Author
-
Wood, Matthew D, Mukherjee, Joydeep, and Pieper, Russell O
- Subjects
Neuroglia ,Cell Line ,Tumor ,Humans ,Neurofibromin 1 ,RNA ,Messenger ,Gene Expression Profiling ,Gene Expression Regulation ,Gene Knockdown Techniques ,Endoglin ,Chitinase-3-Like Protein 1 ,Cell Line ,Tumor ,RNA ,Messenger - Abstract
The neurofibromin-1 tumor suppressor gene (NF1) is altered in approximately 20% of sporadic glioblastoma (GBM) cases. NF1 deficient GBM frequently shows a mesenchymal gene expression signature, suggesting a relationship between NF1 status and the tumor microenvironment. To identify changes in the production of secreted cytokines/chemokines in NF1 deficient glioma, we applied cytokine arrays to conditioned media from a panel of three GBM cell lines after siRNA-mediated NF1 knockdown. We identified increased secretion of platelet-derived growth factor AA (PDGF-AA), chitinase-3-like protein 1 (CHI3L1), interleukin-8 (IL-8), and endoglin (ENG) in different subsets of these cell lines. Secretion was associated with induction of the corresponding messenger RNA, suggesting a mechanism involving transcriptional upregulation. By contrast, in non-transformed immortalized normal human astrocytes, PDGF-AA secretion was increased upon NF1 knockdown, while secreted CHI3L1, ENG, and IL-8 were reduced or unchanged. Analysis of The Cancer Genome Atlas confirmed a relationship between glioma NF1 status and ENG and CHI3L1 in tumor samples. Overall, this study identifies candidate changes in secreted proteins from NF1 deficient glioma cells that could influence the tumor microenvironment, and suggests a direct link between NF1 loss and increased tumor cell production of CHI3L1 and endoglin, two factors implicated in mesenchymal identity in glioblastoma.
- Published
- 2018
16. Genomic analysis of the origins and evolution of multicentric diffuse lower-grade gliomas
- Author
-
Hayes, Josie, Yu, Yao, Jalbert, Llewellyn E, Mazor, Tali, Jones, Lindsey E, Wood, Matthew D, Walsh, Kyle M, Bengtsson, Henrik, Hong, Chibo, Oberndorfer, Stefan, Roetzer, Thomas, Smirnov, Ivan V, Clarke, Jennifer L, Aghi, Manish K, Chang, Susan M, Nelson, Sarah J, Woehrer, Adelheid, Phillips, Joanna J, Solomon, David A, and Costello, Joseph F
- Subjects
Biomedical and Clinical Sciences ,Clinical Sciences ,Oncology and Carcinogenesis ,Brain Disorders ,Orphan Drug ,Brain Cancer ,Genetics ,Biotechnology ,Cancer Genomics ,Cancer ,Neurosciences ,Human Genome ,Rare Diseases ,Clinical Research ,Adult ,Biomarkers ,Tumor ,Brain Neoplasms ,Clonal Evolution ,Female ,Genomics ,Glioma ,Humans ,Male ,Middle Aged ,Mutation ,Neoplasm Grading ,Phylogeny ,Young Adult ,astrocytoma ,bilateral ,IDH1 ,multicentric ,oligodendroglioma ,Oncology & Carcinogenesis ,Oncology and carcinogenesis - Abstract
BackgroundRare multicentric lower-grade gliomas (LGGs) represent a unique opportunity to study the heterogeneity among distinct tumor foci in a single patient and to infer their origins and parallel patterns of evolution.MethodsIn this study, we integrate clinical features, histology, and immunohistochemistry for 4 patients with multicentric LGG, arising both synchronously and metachronously. For 3 patients we analyze the phylogeny of the lesions using exome sequencing, including one case with a total of 8 samples from the 2 lesions.ResultsOne patient was diagnosed with multicentric isocitrate dehydrogenase 1 (IDH1) mutated diffuse astrocytomas harboring distinct IDH1 mutations, R132H and R132C; the latter mutation has been associated with Li-Fraumeni syndrome, which was subsequently confirmed in the patient's germline DNA and shown in additional cases with The Cancer Genome Atlas data. In another patient, phylogenetic analysis of synchronously arising grade II and grade III diffuse astrocytomas demonstrated a single shared mutation, IDH1 R132H, and revealed convergent evolution via non-overlapping mutations in ATRX and TP53. In 2 cases, there was divergent evolution of IDH1-mutated and 1p/19q-codeleted oligodendroglioma and IDH1-mutated and 1p/19q-intact diffuse astrocytoma, occurring synchronously in one case and metachronously in a second.ConclusionsEach tumor in multicentric LGG cases may arise independently or may diverge very early in their development, presenting as genetically and histologically distinct tumors. Comprehensive sampling of these lesions can therefore significantly alter diagnosis and management. Additionally, somatic IDH1 R132C mutation in either multicentric or solitary LGG identifies unsuspected germline TP53 mutation, validating the limited number of published cases.
- Published
- 2018
17. MRI Features and IDH Mutational Status of Grade II Diffuse Gliomas: Impact on Diagnosis and Prognosis.
- Author
-
Villanueva-Meyer, Javier E, Wood, Matthew D, Choi, Byung Se, Mabray, Marc C, Butowski, Nicholas A, Tihan, Tarik, and Cha, Soonmee
- Subjects
Biomedical and Clinical Sciences ,Clinical Sciences ,Brain Disorders ,Cancer ,Brain Cancer ,Biomedical Imaging ,Clinical Research ,Rare Diseases ,Adult ,Age Factors ,Brain Neoplasms ,Contrast Media ,Female ,Glioma ,Humans ,Isocitrate Dehydrogenase ,Magnetic Resonance Imaging ,Male ,Middle Aged ,Neoplasm Grading ,Organometallic Compounds ,Prognosis ,Risk Factors ,grade II diffuse gliomas ,IDH ,isocitrate dehydrogenase ,low-grade glioma ,MRI ,Nuclear Medicine & Medical Imaging ,Clinical sciences - Abstract
ObjectiveGrade II diffuse gliomas (DGs) with isocitrate dehydrogenase (IDH) mutations are associated with better prognosis than their IDH wild-type counterparts. We sought to determine the MRI characteristics associated with IDH mutational status and ascertain whether MRI considered in combination with IDH mutational status can better predict the clinical outcomes of grade II DGs.Materials and methodsPreoperative MRI examinations were retrospectively studied for qualitative tumor characteristics, including location, extent, cortical involvement, margin sharpness, cystic component, mineralization or hemorrhage, and contrast enhancement. Quantitative diffusion and perfusion metrics were also assessed. Logistic regression and ROC analyses were used to evaluate the relationship between MRI features and IDH mutational status. The association between IDH mutational status, 1p19q codeletion, MRI features, extent of resection, and clinical outcomes was assessed by Kaplan-Meier and Cox proportional hazards models.ResultsOf 100 grade II DGs, 78 were IDH mutant and 22 were IDH wild type. IDH wild-type tumors were associated with older age, multifocality, brainstem involvement, lack of cystic change, and a lower apparent diffusion coefficient (ADC). Multivariable regression showed that age older than 45 years as well as low minimum ADC (ADCmin), mean ADC, and maximum ADC values were independently associated with IDH mutational status. Of these, an ADCmin threshold of 0.9 × 10-3 mm2/s or less provided the greatest sensitivity and specificity (91% and 76%, respectively) in defining IDH wild-type grade II DGs. Combining low ADCmin with IDH wild-type status conferred worse outcomes than did IDH wild-type status alone.ConclusionIDH wild-type grade II DGs are associated with a lower ADC and poor clinical outcomes. Combining IDH mutational status and ADC may allow more accurate prediction of clinical outcomes for patients with grade II DGs.
- Published
- 2018
18. Multimodal molecular analysis of astroblastoma enables reclassification of most cases into more specific molecular entities.
- Author
-
Wood, Matthew D, Tihan, Tarik, Perry, Arie, Chacko, Geeta, Turner, Clinton, Pu, Cunfeng, Payne, Christopher, Yu, Alexander, Bannykh, Serguei I, and Solomon, David A
- Subjects
Brain ,Humans ,Neoplasms ,Neuroepithelial ,Brain Neoplasms ,Tumor Suppressor Proteins ,Diagnosis ,Differential ,Immunohistochemistry ,Retrospective Studies ,Phenotype ,Adult ,Aged ,Child ,Female ,Male ,Neoplasm Grading ,Genotyping Techniques ,CNS-HGNET-MN1 ,DNA methylation profiling ,astroblastoma ,next-generation sequencing ,Trans-Activators ,Neoplasms ,Neuroepithelial ,Diagnosis ,Differential ,Brain Disorders ,Biotechnology ,Cancer ,Brain Cancer ,Genetics ,Human Genome ,Genetic Testing ,Rare Diseases ,Neurosciences ,2.1 Biological and endogenous factors ,Clinical Sciences ,Neurology & Neurosurgery - Abstract
Astroblastoma is a rare and controversial glioma with variable clinical behavior. The diagnosis currently rests on histologic findings of a circumscribed glioma with astroblastomatous pseudorosettes and vascular hyalinization. Immunohistochemical studies have suggested different oncogenic drivers, such as BRAF p.V600E, but very few cases have been studied using genome-wide methodologies. Recent genomic profiling identified a subset of CNS embryonal tumors with astroblastoma-like morphology that harbored MN1 gene fusions, termed "CNS high-grade neuroepithelial tumors with MN1 alteration" (CNS-HGNET-MN1). To further characterize the genetic alterations that drive astroblastomas, we performed targeted next-generation sequencing (NGS) of 500 cancer-associated genes in a series of eight cases. We correlated these findings with break-apart fluorescence in situ hybridization (FISH) analysis of the MN1 locus and genome-wide DNA methylation profiling. Four cases showed MN1 alteration by FISH, including two pediatric cases that lacked other pathogenic alterations, and two adult cases that harbored other cancer-associated gene mutations or copy number alterations (eg, CDKN2A/B homozygous deletion, TP53, ATM and TERT promoter mutations). Three of these cases grouped with the CNS-HGNET-MN1 entity by methylation profiling. Two of four MN1 intact cases by FISH showed genetic features of either anaplastic pleomorphic xanthoastrocytoma (BRAF p.V600E mutation, CDKN2A/B homozygous deletion and TERT promoter mutation) or IDH-wildtype glioblastoma (trisomy 7, monosomy 10, CDK4 amplification and TP53, NRAS and TERT promoter mutations) and these cases had an aggressive clinical course. Two clinically indolent cases remained unclassifiable despite multimodal molecular analysis. We conclude that astroblastoma histology is not specific for any entity including CNS-HGNET-MN1, and that additional genetic characterization should be considered for astroblastomas, as a number of these tumors likely contain a methylation profile or genetic alterations that suggest classification as other tumor entities. Our heterogeneous molecular findings help to explain the clinical unpredictability of astroblastoma.
- Published
- 2018
19. Supplementary Figures S1-S5 from Combined Immunotherapy Improves Outcome for Replication-Repair-Deficient (RRD) High-Grade Glioma Failing Anti–PD-1 Monotherapy: A Report from the International RRD Consortium
- Author
-
Das, Anirban, primary, Fernandez, Nicholas R., primary, Levine, Adrian, primary, Bianchi, Vanessa, primary, Stengs, Lucie K., primary, Chung, Jiil, primary, Negm, Logine, primary, Dimayacyac, Jose Rafael, primary, Chang, Yuan, primary, Nobre, Liana, primary, Ercan, Ayse B., primary, Sanchez-Ramirez, Santiago, primary, Sudhaman, Sumedha, primary, Edwards, Melissa, primary, Larouche, Valerie, primary, Samuel, David, primary, Van Damme, An, primary, Gass, David, primary, Ziegler, David S., primary, Bielack, Stefan S., primary, Koschmann, Carl, primary, Zelcer, Shayna, primary, Yalon-Oren, Michal, primary, Campino, Gadi Abede, primary, Sarosiek, Tomasz, primary, Nichols, Kim E., primary, Loret De Mola, Rebecca, primary, Bielamowicz, Kevin, primary, Sabel, Magnus, primary, Frojd, Charlotta A., primary, Wood, Matthew D., primary, Glover, Jason M., primary, Lee, Yi-Yen, primary, Vanan, Magimairajan, primary, Adamski, Jenny K., primary, Perreault, Sebastien, primary, Chamdine, Omar, primary, Hjort, Magnus Aasved, primary, Zapotocky, Michal, primary, Carceller, Fernando, primary, Wright, Erin, primary, Fedorakova, Ivana, primary, Lossos, Alexander, primary, Tanaka, Ryuma, primary, Osborn, Michael, primary, Blumenthal, Deborah T., primary, Aronson, Melyssa, primary, Bartels, Ute, primary, Huang, Annie, primary, Ramaswamy, Vijay, primary, Malkin, David, primary, Shlien, Adam, primary, Villani, Anita, primary, Dirks, Peter B., primary, Pugh, Trevor J., primary, Getz, Gad, primary, Maruvka, Yosef E., primary, Tsang, Derek S., primary, Ertl-Wagner, Birgit, primary, Hawkins, Cynthia, primary, Bouffet, Eric, primary, Morgenstern, Daniel A., primary, and Tabori, Uri, primary
- Published
- 2024
- Full Text
- View/download PDF
20. Combined Immunotherapy Improves Outcome for Replication-Repair-Deficient (RRD) High-Grade Glioma Failing Anti–PD-1 Monotherapy: A Report from the International RRD Consortium
- Author
-
Das, Anirban, primary, Fernandez, Nicholas R., additional, Levine, Adrian, additional, Bianchi, Vanessa, additional, Stengs, Lucie K., additional, Chung, Jiil, additional, Negm, Logine, additional, Dimayacyac, Jose Rafael, additional, Chang, Yuan, additional, Nobre, Liana, additional, Ercan, Ayse B., additional, Sanchez-Ramirez, Santiago, additional, Sudhaman, Sumedha, additional, Edwards, Melissa, additional, Larouche, Valerie, additional, Samuel, David, additional, Van Damme, An, additional, Gass, David, additional, Ziegler, David S., additional, Bielack, Stefan S., additional, Koschmann, Carl, additional, Zelcer, Shayna, additional, Yalon-Oren, Michal, additional, Campino, Gadi Abede, additional, Sarosiek, Tomasz, additional, Nichols, Kim E., additional, Loret De Mola, Rebecca, additional, Bielamowicz, Kevin, additional, Sabel, Magnus, additional, Frojd, Charlotta A., additional, Wood, Matthew D., additional, Glover, Jason M., additional, Lee, Yi-Yen, additional, Vanan, Magimairajan, additional, Adamski, Jenny K., additional, Perreault, Sebastien, additional, Chamdine, Omar, additional, Hjort, Magnus Aasved, additional, Zapotocky, Michal, additional, Carceller, Fernando, additional, Wright, Erin, additional, Fedorakova, Ivana, additional, Lossos, Alexander, additional, Tanaka, Ryuma, additional, Osborn, Michael, additional, Blumenthal, Deborah T., additional, Aronson, Melyssa, additional, Bartels, Ute, additional, Huang, Annie, additional, Ramaswamy, Vijay, additional, Malkin, David, additional, Shlien, Adam, additional, Villani, Anita, additional, Dirks, Peter B., additional, Pugh, Trevor J., additional, Getz, Gad, additional, Maruvka, Yosef E., additional, Tsang, Derek S., additional, Ertl-Wagner, Birgit, additional, Hawkins, Cynthia, additional, Bouffet, Eric, additional, Morgenstern, Daniel A., additional, and Tabori, Uri, additional
- Published
- 2024
- Full Text
- View/download PDF
21. Obesity and meningioma: a US population-based study paired with analysis of a multi-institutional cohort
- Author
-
Khazanchi, Rushmin, primary, Nandoliya, Khizar R., additional, Shahin, Maryam N., additional, Rae, Ali I., additional, Chaliparambil, Rahul K., additional, Bowden, Stephen G., additional, Alwakeal, Amr, additional, Lopez Ramos, Christian G., additional, Stedelin, Brittany, additional, Youngblood, Mark W., additional, Chandler, James P., additional, Lukas, Rimas V., additional, Sanusi, Olabisi R., additional, Dogan, Aclan, additional, Wood, Matthew D., additional, Han, Seunggu J., additional, and Magill, Stephen T., additional
- Published
- 2024
- Full Text
- View/download PDF
22. Metastatic clival chordoma: a case report of multiple extraneural metastases following resection and proton beam radiotherapy in a 5-year old boy.
- Author
-
Rutkowski, Martin J, Birk, Harjus S, Wood, Matthew D, Perry, Arie, Nicolaides, Theodore, Ames, Christopher P, and Gupta, Nalin
- Subjects
Biomedical and Clinical Sciences ,Clinical Sciences ,Oncology and Carcinogenesis ,Cancer ,Child ,Preschool ,Chordoma ,Combined Modality Therapy ,Humans ,Male ,Proton Therapy ,Skull Base Neoplasms ,chordoma ,clival ,intracranial ,metastasis ,recurrence ,proton beam ,transoral ,oncology ,EMA = epithelial membrane antigen ,PBRT = proton beam radiotherapy ,VP = ventriculoperitoneal ,Paediatrics and Reproductive Medicine ,Neurology & Neurosurgery ,Neurosciences ,Paediatrics - Abstract
The authors report the case of a 5-year-old boy in whom extraneural metastases developed 5 years after he underwent an occipitocervical fusion and transoral approach to treat a clival chordoma without local recurrence. Following primary resection, the patient's postoperative course was complicated by recurrent meningitis secondary to CSF leak, which responded to antibiotics, and communicating hydrocephalus, for which a ventriculoperitoneal shunt was placed. The patient then underwent postoperative proton beam radiotherapy. Five years following his initial presentation, surveillance imaging revealed a new asymptomatic lung mass for which the patient underwent thoracotomy and resection of the mass. Histological examination of the lung mass revealed findings consistent with a de-differentiated chordoma, confirming extraneural metastasis from the original tumor without evidence of local recurrence. Chest wall and scalp metastases subsequently developed, and the patient was started on an adjuvant chemotherapy regimen that included imatinib and rapamycin followed by subsequent nivolumab and an EZH2 inhibitor for recurrent, disseminated disease. Despite this patient's remote and distant metastases, primary gross-total resection for chordoma remains a critical treatment objective, followed by proton beam radiotherapy. This case illustrates the importance of interval posttreatment imaging and the emerging potential to treat chordoma with molecularly targeted therapies.
- Published
- 2017
23. Protein Analysis of Glioblastoma Primary and Posttreatment Pairs Suggests a Mesenchymal Shift at Recurrence
- Author
-
Wood, Matthew D, Reis, Gerald F, Reuss, David E, and Phillips, Joanna J
- Subjects
Biomedical and Clinical Sciences ,Oncology and Carcinogenesis ,Genetics ,Neurosciences ,Brain Disorders ,Brain Cancer ,Rare Diseases ,Cancer ,Glioblastoma ,Glioblastoma molecular subtype ,Immunohistochemistry ,Mesenchymal transition ,Neurofibromin ,Recurrent glioblastoma ,Recurrent glioblastoma. ,Clinical Sciences ,Neurology & Neurosurgery ,Clinical sciences - Abstract
Glioblastomas (GBM) are aggressive brain tumors that inevitably recur despite surgical resection, chemotherapy, and radiation. The degree to which recurrent GBM retains its initial immunophenotype is incompletely understood. We generated tissue microarrays of paired initial and posttreatment GBM (3 pairs positive and 17 negative for IDH1R132H) from the same patients and made comparisons in the IDH1R132H-negative group for immunohistochemical and gene expression differences between primary and recurrent tumors. In initial tumors, immunopositivity for Ki-67 in > 20% of tumor cells was associated with shorter progression-free and overall survival. Recurrent tumors showed decreased staining for CD34 suggesting lower vessel density. A subset of tumors showed increased staining for markers associated with the mesenchymal gene expression pattern, including CD44, phosphorylated STAT3, and YKL40. Recurrent tumors with the greatest increase in mesenchymal marker expression had rapid clinical progression, but no difference in overall survival after second surgery. Comparison of protein and gene expression data from the same samples revealed a poor correlation. A subset of tumors (15%) showed loss of neurofibromin protein in both initial and recurrent tumors. These data support the notion that GBM progression is associated with a shift toward a mesenchymal phenotype in a subset of tumors and this may portend a more aggressive behavior.
- Published
- 2016
24. Updates in Pediatric Glioma Pathology
- Author
-
Hakar, Melanie H. and Wood, Matthew D.
- Published
- 2020
- Full Text
- View/download PDF
25. New in vitro highly cytotoxic platinum and palladium cyanoximates with minimal side effects in vivo
- Author
-
Dannen, Stephanie D., Cornelison, Lauren, Durham, Paul, Morley, John E., Shahverdi, Kiana, Du, Junwei, Zhou, Haiying, Sudlow, Leland C., Hunter, Daniel, Wood, Matthew D., Berezin, Mikhail Y., and Gerasimchuk, Nikolay
- Published
- 2020
- Full Text
- View/download PDF
26. Diffuse Midline Gliomas with Histone H3‐K27M Mutation: A Series of 47 Cases Assessing the Spectrum of Morphologic Variation and Associated Genetic Alterations
- Author
-
Solomon, David A, Wood, Matthew D, Tihan, Tarik, Bollen, Andrew W, Gupta, Nalin, Phillips, Joanna JJ, and Perry, Arie
- Subjects
Biomedical and Clinical Sciences ,Clinical Sciences ,Oncology and Carcinogenesis ,Rare Diseases ,Neurosciences ,Brain Cancer ,Cancer ,Brain Disorders ,Pediatric Research Initiative ,Genetics ,2.1 Biological and endogenous factors ,Aetiology ,Adolescent ,Adult ,Aged ,Brain Neoplasms ,Child ,Child ,Preschool ,ErbB Receptors ,Female ,Gene Expression Regulation ,Neoplastic ,Genetic Association Studies ,Glioma ,Glycine ,Histones ,Humans ,Isocitrate Dehydrogenase ,Male ,Methionine ,Middle Aged ,Mutation ,PTEN Phosphohydrolase ,Tumor Suppressor Protein p53 ,X-linked Nuclear Protein ,Young Adult ,astrocytoma ,diffuse midline glioma ,diffuse intrinsic pontine glioma ,DIPG ,glioblastoma ,histone H3 ,1 ,3 ,H3F3A ,HIST1H3B ,K27M mutation ,histone H3.1 ,histone H3.3 ,Neurology & Neurosurgery ,Clinical sciences - Abstract
Somatic mutations of the H3F3A and HIST1H3B genes encoding the histone H3 variants, H3.3 and H3.1, were recently identified in high-grade gliomas arising in the thalamus, pons and spinal cord of children and young adults. However, the complete range of patients and locations in which these tumors arise, as well as the morphologic spectrum and associated genetic alterations remain undefined. Here, we describe a series of 47 diffuse midline gliomas with histone H3-K27M mutation. The 25 male and 22 female patients ranged in age from 2 to 65 years (median = 14). Tumors were centered not only in the pons, thalamus, and spinal cord, but also in the third ventricle, hypothalamus, pineal region and cerebellum. Patients with pontine tumors were younger (median = 7 years) than those with thalamic (median = 24 years) or spinal (median = 25 years) tumors. A wide morphologic spectrum was encountered including gliomas with giant cells, epithelioid and rhabdoid cells, primitive neuroectodermal tumor (PNET)-like foci, neuropil-like islands, pilomyxoid features, ependymal-like areas, sarcomatous transformation, ganglionic differentiation and pleomorphic xanthoastrocytoma (PXA)-like areas. In this series, histone H3-K27M mutation was mutually exclusive with IDH1 mutation and EGFR amplification, rarely co-occurred with BRAF-V600E mutation, and was commonly associated with p53 overexpression, ATRX loss (except in pontine gliomas), and monosomy 10.
- Published
- 2016
27. Enhanced efficiency urea fertilizers and timing effects on N2O emissions from spring wheat production in Manitoba
- Author
-
Wood, Matthew D., primary, Gao, Xiaopeng, additional, Tiessen, Kevin H. D., additional, Tenuta, Mario, additional, and Flaten, Donald N., additional
- Published
- 2023
- Full Text
- View/download PDF
28. Cystic appearance on magnetic resonance imaging in bihormonal growth hormone and prolactin tumors in acromegaly
- Author
-
Varlamov, Elena V., Wood, Matthew D., Netto, Joao Prola, Thiessen, Jaclyn, Kim, Jung, Lim, Dawn Shao Ting, Yedinak, Christine G., Banskota, Swechya, Cetas, Justin S., and Fleseriu, Maria
- Published
- 2020
- Full Text
- View/download PDF
29. Diagnosing Balamuthia mandrillaris Encephalitis With Metagenomic Deep Sequencing
- Author
-
Wilson, Michael R, Shanbhag, Niraj M, Reid, Michael J, Singhal, Neel S, Gelfand, Jeffrey M, Sample, Hannah A, Benkli, Barlas, O'Donovan, Brian D, Ali, Ibne KM, Keating, M Kelly, Dunnebacke, Thelma H, Wood, Matthew D, Bollen, Andrew, and DeRisi, Joseph L
- Subjects
Biomedical and Clinical Sciences ,Clinical Sciences ,Biotechnology ,Infectious Diseases ,Neurosciences ,Aetiology ,2.1 Biological and endogenous factors ,4.1 Discovery and preclinical testing of markers and technologies ,Detection ,screening and diagnosis ,Infection ,Good Health and Well Being ,Aged ,Amebiasis ,Animals ,Balamuthia mandrillaris ,Brain ,DNA ,Protozoan ,Female ,Genomics ,Humans ,Meningoencephalitis ,Polymerase Chain Reaction ,Sequence Analysis ,RNA ,Vitreous Body ,Neurology & Neurosurgery ,Clinical sciences - Abstract
ObjectiveIdentification of a particular cause of meningoencephalitis can be challenging owing to the myriad bacteria, viruses, fungi, and parasites that can produce overlapping clinical phenotypes, frequently delaying diagnosis and therapy. Metagenomic deep sequencing (MDS) approaches to infectious disease diagnostics are known for their ability to identify unusual or novel viruses and thus are well suited for investigating possible etiologies of meningoencephalitis.MethodsWe present the case of a 74-year-old woman with endophthalmitis followed by meningoencephalitis. MDS of her cerebrospinal fluid (CSF) was performed to identify an infectious agent.ResultsSequences aligning to Balamuthia mandrillaris ribosomal RNA genes were identified in the CSF by MDS. Polymerase chain reaction subsequently confirmed the presence of B. mandrillaris in CSF, brain tissue, and vitreous fluid from the patient's infected eye. B. mandrillaris serology and immunohistochemistry for free-living amoebas on the brain biopsy tissue were positive.InterpretationThe diagnosis was made using MDS after the patient had been hospitalized for several weeks and subjected to costly and invasive testing. MDS is a powerful diagnostic tool with the potential for rapid and unbiased pathogen identification leading to early therapeutic targeting.
- Published
- 2015
30. Defining, measuring, and enhancing resilience for small groups
- Author
-
Zemba, Valerie, Wells, Emily M., Wood, Matthew D., Trump, Benjamin D., Boyle, Bridget, Blue, Shala, Cato, Colanda, and Linkov, Igor
- Published
- 2019
- Full Text
- View/download PDF
31. Technology Infusion and Marketing
- Author
-
Wood, Matthew D., Thorne, Sarah, Butte, Gordon, Linkov, Igor, Series editor, Keisler, Jeffrey, Series editor, Lambert, James H., Series editor, Figueira, Jose, Series editor, Wood, Matthew D., Thorne, Sarah, Kovacs, Daniel, and Butte, Gordon
- Published
- 2017
- Full Text
- View/download PDF
32. Adaptive Management for Climate Change
- Author
-
Wood, Matthew D., Thorne, Sarah, Butte, Gordon, Linkov, Igor, Kovacs, Daniel, Linkov, Igor, Series editor, Keisler, Jeffrey, Series editor, Lambert, James H., Series editor, Figueira, Jose, Series editor, Wood, Matthew D., Thorne, Sarah, Kovacs, Daniel, and Butte, Gordon
- Published
- 2017
- Full Text
- View/download PDF
33. Science of Mental Modeling
- Author
-
Wood, Matthew D., Linkov, Igor, Linkov, Igor, Series editor, Keisler, Jeffrey, Series editor, Lambert, James H., Series editor, Figueira, Jose, Series editor, Wood, Matthew D., Thorne, Sarah, Kovacs, Daniel, and Butte, Gordon
- Published
- 2017
- Full Text
- View/download PDF
34. Flood Risk Management
- Author
-
Wood, Matthew D., Linkov, Igor, Kovacs, Daniel, Butte, Gordon, Linkov, Igor, Series editor, Keisler, Jeffrey, Series editor, Lambert, James H., Series editor, Figueira, Jose, Series editor, Wood, Matthew D., Thorne, Sarah, Kovacs, Daniel, and Butte, Gordon
- Published
- 2017
- Full Text
- View/download PDF
35. Mental Modeling Research Technical Approach
- Author
-
Thorne, Sarah, Butte, Gordon, Kovacs, Daniel, Wood, Matthew D., Linkov, Igor, Series editor, Keisler, Jeffrey, Series editor, Lambert, James H., Series editor, Figueira, Jose, Series editor, Wood, Matthew D., Thorne, Sarah, Kovacs, Daniel, and Butte, Gordon
- Published
- 2017
- Full Text
- View/download PDF
36. An Introduction to Mental Modeling
- Author
-
Wood, Matthew D., Thorne, Sarah, Kovacs, Daniel, Butte, Gordon, Linkov, Igor, Linkov, Igor, Series editor, Keisler, Jeffrey, Series editor, Lambert, James H., Series editor, Figueira, Jose, Series editor, Wood, Matthew D., Thorne, Sarah, Kovacs, Daniel, and Butte, Gordon
- Published
- 2017
- Full Text
- View/download PDF
37. Numerical chromosomal instability mediates susceptibility to radiation treatment
- Author
-
Bakhoum, Samuel F, Kabeche, Lilian, Wood, Matthew D, Laucius, Christopher D, Qu, Dian, Laughney, Ashley M, Reynolds, Gloria E, Louie, Raymond J, Phillips, Joanna, Chan, Denise A, Zaki, Bassem I, Murnane, John P, Petritsch, Claudia, and Compton, Duane A
- Subjects
Biochemistry and Cell Biology ,Biomedical and Clinical Sciences ,Oncology and Carcinogenesis ,Biological Sciences ,Human Genome ,Genetics ,Cancer ,Aneuploidy ,Animals ,Brain Neoplasms ,Cell Cycle ,Cell Death ,Cell Line ,Tumor ,Cell Survival ,Chromosomal Instability ,Chromosome Breakage ,Chromosome Segregation ,Glioblastoma ,HCT116 Cells ,Humans ,Male ,Mice ,Mice ,Nude ,Micronucleus Tests ,Mitosis ,Neoplasm Transplantation ,Neoplasms ,Radiation ,Ionizing - Abstract
The exquisite sensitivity of mitotic cancer cells to ionizing radiation (IR) underlies an important rationale for the widely used fractionated radiation therapy. However, the mechanism for this cell cycle-dependent vulnerability is unknown. Here we show that treatment with IR leads to mitotic chromosome segregation errors in vivo and long-lasting aneuploidy in tumour-derived cell lines. These mitotic errors generate an abundance of micronuclei that predispose chromosomes to subsequent catastrophic pulverization thereby independently amplifying radiation-induced genome damage. Experimentally suppressing whole-chromosome missegregation reduces downstream chromosomal defects and significantly increases the viability of irradiated mitotic cells. Further, orthotopically transplanted human glioblastoma tumours in which chromosome missegregation rates have been reduced are rendered markedly more resistant to IR, exhibiting diminished markers of cell death in response to treatment. This work identifies a novel mitotic pathway for radiation-induced genome damage, which occurs outside of the primary nucleus and augments chromosomal breaks. This relationship between radiation treatment and whole-chromosome missegregation can be exploited to modulate therapeutic response in a clinically relevant manner.
- Published
- 2015
38. Quantifying and mapping resilience within large organizations
- Author
-
Wood, Matthew D., Wells, Emily M., Rice, Glenn, and Linkov, Igor
- Published
- 2019
- Full Text
- View/download PDF
39. Effect of Veau Class on Levator Veli Palatini Muscle Composition.
- Author
-
Chiang, Sarah N, Meyer, Gretchen A, Skolnick, Gary B, Hunter, Daniel A, Wood, Matthew D, Li, Xiaowei, Snyder-Warwick, Alison K, and Patel, Kamlesh B
- Subjects
CLEFT palate ,VELOPHARYNGEAL insufficiency ,RESEARCH funding ,FLUORESCENT antibody technique ,HISTOLOGICAL techniques ,PALATAL muscles ,LONGITUDINAL method - Abstract
Objective: To examine levator veli palatini muscle composition in patients with nonsyndromic cleft palate and investigate the impact of Veau class. Design: Prospective cohort study. Setting: Tertiary care academic hospital. Patients/Participants: Thirteen patients with nonsyndromic cleft palate were recruited. Interventions: During primary palatoplasty, a sample of levator veli palatini muscle was excised and prepared for histological analysis. Main Outcome Measures: Fat and collagen content were determined utilizing Oil Red and Sirius red stains, respectively, while muscle fiber cross-sectional areas were calculated from H&E-stained samples, with analysis using histomorphometric methods. Immunofluorescent staining of myosin heavy chain isoforms was performed. Results: Patients underwent repair at 10.8 months of age (interquartile range [IQR] 10.2-12.9). Fat content of the levator veli palatini muscle was low in both groups, ranging from 0% to 5.2%. Collagen content ranged from 8.5% to 39.8%; neither fat nor collagen content showed an association with Veau classes. Mean muscle fiber cross-sectional area decreased with increasing Veau class, from 808 µm
2 (range 692-995 µm2 ) in Veau II to 651 µm2 (range 232-750 µm2 ) in Veau III (P =.02). There was also a nonsignificant decrease in proportion of type I muscle fibers with increasing Veau class (44.3% [range 31.4%-84.4%] in Veau II vs 35.3% [range 17.4%-61.3%] in Veau III). Conclusions: Muscle fiber area in levator veli palatini muscles decreases in Veau III clefts in comparison to Veau II. The impact of these differences in velopharyngeal dysfunction requires further analysis of a larger cohort. [ABSTRACT FROM AUTHOR]- Published
- 2024
- Full Text
- View/download PDF
40. Enhanced efficiency urea fertilizers and timing effects on N2O emissions from spring wheat production in Manitoba.
- Author
-
Wood, Matthew D., Gao, Xiaopeng, Tiessen, Kevin H. D., Tenuta, Mario, and Flaten, Donald N.
- Abstract
Opportunities exist to reduce nitrous oxide (N2O) emissions from nitrogen (N) fertilizers using enhanced efficiency fertilizers (EEFs) and managing application timing. This study examined (1) application timing (fall/spring) and (2) fertilizer N source on N2O emissions, yield, and N uptake of Canadian hard red spring wheat (Triticum aestivum L.) in Southern Manitoba. Fertilizer N sources included granular urea and four EEF products: (1) polymer‐coated urea (environmentally smart nitrogen [ESN]); (2) urea plus nitrification inhibitor (eNtrench); (3) urea plus urease inhibitor (Limus); and (4) urea plus nitrification and urease inhibitor (SuperU). Nitrification‐inhibited products most consistently reduced N2O emissions while maintaining productivity. Compared to urea alone, urea + eNtrench was most effective in reducing cumulative N2O emissions by 47%–64% at four of six site‐years. SuperU reduced N2O emissions by 37%–57% at three of six site‐years. ESN and urea + Limus did not affect emissions in most years. Wheat yield, protein, and N uptake were unaffected by N source in five of six site‐years. Compared to spring, fall application gave greater N2O emissions by 33%–67% at three of six site‐years due to spring‐thaw emissions. Fall was inferior to spring application in wetter site years with lower yield, protein, and N uptake. Overall, nitrification‐inhibited products—either alone or with a urease inhibitor—are a promising tool to reduce N2O emissions while maintaining wheat productivity in Manitoba. However, given that there were few consistent increases in yield or protein, the additional cost of the inhibitors will be a barrier to adoption. Core Ideas: EEF products with nitrification and nitrification/urease inhibitors consistently reduced N2O emissions.Controlled release urea and urease‐inhibited urea did not reduce N2O emissions.Fall application of urea increased N2O emissions in three site‐years compared to spring application.The nitrification inhibitors applied with urea in fall or spring were effective to reduce N2O emissions.Overall, fall application decreased yield, grain protein, and N uptake in relatively wet years. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
41. Development of community of practice to support quantitative risk assessment for synthetic biology products: contaminant bioremediation and invasive carp control as cases
- Author
-
Trump, Benjamin D., Foran, Christy, Rycroft, Taylor, Wood, Matthew D., Bandolin, Nirzwan, Cains, Mariana, Cary, Timothy, Crocker, Fiona, Friedenberg, Nicholas A., Gurian, Patrick, Hamilton, Kerry, Hoover, Jan Jeffrey, Meyer, Corey, Pokrzywinski, Kaytee, Ritterson, Ryan, Schulte, Paul, Warner, Christopher, Perkins, Edward, and Linkov, Igor
- Published
- 2018
- Full Text
- View/download PDF
42. Abstract 5012: Characterizing the functional significance of PDGFRAK385I and PDGFRAK385L extracellular domain mutations in the newly defined myxoid glioneuronal tumor
- Author
-
Beach, Catherine Z., primary, Somwar, Romel, additional, Wood, Matthew D., additional, and Davare, Monika A., additional
- Published
- 2023
- Full Text
- View/download PDF
43. Data from Infant High-Grade Gliomas Comprise Multiple Subgroups Characterized by Novel Targetable Gene Fusions and Favorable Outcomes
- Author
-
Clarke, Matthew, primary, Mackay, Alan, primary, Ismer, Britta, primary, Pickles, Jessica C., primary, Tatevossian, Ruth G., primary, Newman, Scott, primary, Bale, Tejus A., primary, Stoler, Iris, primary, Izquierdo, Elisa, primary, Temelso, Sara, primary, Carvalho, Diana M., primary, Molinari, Valeria, primary, Burford, Anna, primary, Howell, Louise, primary, Virasami, Alex, primary, Fairchild, Amy R., primary, Avery, Aimee, primary, Chalker, Jane, primary, Kristiansen, Mark, primary, Haupfear, Kelly, primary, Dalton, James D., primary, Orisme, Wilda, primary, Wen, Ji, primary, Hubank, Michael, primary, Kurian, Kathreena M., primary, Rowe, Catherine, primary, Maybury, Mellissa, primary, Crosier, Stephen, primary, Knipstein, Jeffrey, primary, Schüller, Ulrich, primary, Kordes, Uwe, primary, Kram, David E., primary, Snuderl, Matija, primary, Bridges, Leslie, primary, Martin, Andrew J., primary, Doey, Lawrence J., primary, Al-Sarraj, Safa, primary, Chandler, Christopher, primary, Zebian, Bassel, primary, Cairns, Claire, primary, Natrajan, Rachael, primary, Boult, Jessica K.R., primary, Robinson, Simon P., primary, Sill, Martin, primary, Dunkel, Ira J., primary, Gilheeney, Stephen W., primary, Rosenblum, Marc K., primary, Hughes, Debbie, primary, Proszek, Paula Z., primary, Macdonald, Tobey J., primary, Preusser, Matthias, primary, Haberler, Christine, primary, Slavc, Irene, primary, Packer, Roger, primary, Ng, Ho-Keung, primary, Caspi, Shani, primary, Popović, Mara, primary, Faganel Kotnik, Barbara, primary, Wood, Matthew D., primary, Baird, Lissa, primary, Davare, Monika Ashok, primary, Solomon, David A., primary, Olsen, Thale Kristin, primary, Brandal, Petter, primary, Farrell, Michael, primary, Cryan, Jane B., primary, Capra, Michael, primary, Karremann, Michael, primary, Schittenhelm, Jens, primary, Schuhmann, Martin U., primary, Ebinger, Martin, primary, Dinjens, Winand N.M., primary, Kerl, Kornelius, primary, Hettmer, Simone, primary, Pietsch, Torsten, primary, Andreiuolo, Felipe, primary, Driever, Pablo Hernáiz, primary, Korshunov, Andrey, primary, Hiddingh, Lotte, primary, Worst, Barbara C., primary, Sturm, Dominik, primary, Zuckermann, Marc, primary, Witt, Olaf, primary, Bloom, Tabitha, primary, Mitchell, Clare, primary, Miele, Evelina, primary, Colafati, Giovanna Stefania, primary, Diomedi-Camassei, Francesca, primary, Bailey, Simon, primary, Moore, Andrew S., primary, Hassall, Timothy E.G., primary, Lowis, Stephen P., primary, Tsoli, Maria, primary, Cowley, Mark J., primary, Ziegler, David S., primary, Karajannis, Matthias A., primary, Aquilina, Kristian, primary, Hargrave, Darren R., primary, Carceller, Fernando, primary, Marshall, Lynley V., primary, von Deimling, Andreas, primary, Kramm, Christof M., primary, Pfister, Stefan M., primary, Sahm, Felix, primary, Baker, Suzanne J., primary, Mastronuzzi, Angela, primary, Carai, Andrea, primary, Vinci, Maria, primary, Capper, David, primary, Popov, Sergey, primary, Ellison, David W., primary, Jacques, Thomas S., primary, Jones, David T.W., primary, and Jones, Chris, primary
- Published
- 2023
- Full Text
- View/download PDF
44. Supplementary Data from Infant High-Grade Gliomas Comprise Multiple Subgroups Characterized by Novel Targetable Gene Fusions and Favorable Outcomes
- Author
-
Clarke, Matthew, primary, Mackay, Alan, primary, Ismer, Britta, primary, Pickles, Jessica C., primary, Tatevossian, Ruth G., primary, Newman, Scott, primary, Bale, Tejus A., primary, Stoler, Iris, primary, Izquierdo, Elisa, primary, Temelso, Sara, primary, Carvalho, Diana M., primary, Molinari, Valeria, primary, Burford, Anna, primary, Howell, Louise, primary, Virasami, Alex, primary, Fairchild, Amy R., primary, Avery, Aimee, primary, Chalker, Jane, primary, Kristiansen, Mark, primary, Haupfear, Kelly, primary, Dalton, James D., primary, Orisme, Wilda, primary, Wen, Ji, primary, Hubank, Michael, primary, Kurian, Kathreena M., primary, Rowe, Catherine, primary, Maybury, Mellissa, primary, Crosier, Stephen, primary, Knipstein, Jeffrey, primary, Schüller, Ulrich, primary, Kordes, Uwe, primary, Kram, David E., primary, Snuderl, Matija, primary, Bridges, Leslie, primary, Martin, Andrew J., primary, Doey, Lawrence J., primary, Al-Sarraj, Safa, primary, Chandler, Christopher, primary, Zebian, Bassel, primary, Cairns, Claire, primary, Natrajan, Rachael, primary, Boult, Jessica K.R., primary, Robinson, Simon P., primary, Sill, Martin, primary, Dunkel, Ira J., primary, Gilheeney, Stephen W., primary, Rosenblum, Marc K., primary, Hughes, Debbie, primary, Proszek, Paula Z., primary, Macdonald, Tobey J., primary, Preusser, Matthias, primary, Haberler, Christine, primary, Slavc, Irene, primary, Packer, Roger, primary, Ng, Ho-Keung, primary, Caspi, Shani, primary, Popović, Mara, primary, Faganel Kotnik, Barbara, primary, Wood, Matthew D., primary, Baird, Lissa, primary, Davare, Monika Ashok, primary, Solomon, David A., primary, Olsen, Thale Kristin, primary, Brandal, Petter, primary, Farrell, Michael, primary, Cryan, Jane B., primary, Capra, Michael, primary, Karremann, Michael, primary, Schittenhelm, Jens, primary, Schuhmann, Martin U., primary, Ebinger, Martin, primary, Dinjens, Winand N.M., primary, Kerl, Kornelius, primary, Hettmer, Simone, primary, Pietsch, Torsten, primary, Andreiuolo, Felipe, primary, Driever, Pablo Hernáiz, primary, Korshunov, Andrey, primary, Hiddingh, Lotte, primary, Worst, Barbara C., primary, Sturm, Dominik, primary, Zuckermann, Marc, primary, Witt, Olaf, primary, Bloom, Tabitha, primary, Mitchell, Clare, primary, Miele, Evelina, primary, Colafati, Giovanna Stefania, primary, Diomedi-Camassei, Francesca, primary, Bailey, Simon, primary, Moore, Andrew S., primary, Hassall, Timothy E.G., primary, Lowis, Stephen P., primary, Tsoli, Maria, primary, Cowley, Mark J., primary, Ziegler, David S., primary, Karajannis, Matthias A., primary, Aquilina, Kristian, primary, Hargrave, Darren R., primary, Carceller, Fernando, primary, Marshall, Lynley V., primary, von Deimling, Andreas, primary, Kramm, Christof M., primary, Pfister, Stefan M., primary, Sahm, Felix, primary, Baker, Suzanne J., primary, Mastronuzzi, Angela, primary, Carai, Andrea, primary, Vinci, Maria, primary, Capper, David, primary, Popov, Sergey, primary, Ellison, David W., primary, Jacques, Thomas S., primary, Jones, David T.W., primary, and Jones, Chris, primary
- Published
- 2023
- Full Text
- View/download PDF
45. Supplementary Table S3 from Infant High-Grade Gliomas Comprise Multiple Subgroups Characterized by Novel Targetable Gene Fusions and Favorable Outcomes
- Author
-
Clarke, Matthew, primary, Mackay, Alan, primary, Ismer, Britta, primary, Pickles, Jessica C., primary, Tatevossian, Ruth G., primary, Newman, Scott, primary, Bale, Tejus A., primary, Stoler, Iris, primary, Izquierdo, Elisa, primary, Temelso, Sara, primary, Carvalho, Diana M., primary, Molinari, Valeria, primary, Burford, Anna, primary, Howell, Louise, primary, Virasami, Alex, primary, Fairchild, Amy R., primary, Avery, Aimee, primary, Chalker, Jane, primary, Kristiansen, Mark, primary, Haupfear, Kelly, primary, Dalton, James D., primary, Orisme, Wilda, primary, Wen, Ji, primary, Hubank, Michael, primary, Kurian, Kathreena M., primary, Rowe, Catherine, primary, Maybury, Mellissa, primary, Crosier, Stephen, primary, Knipstein, Jeffrey, primary, Schüller, Ulrich, primary, Kordes, Uwe, primary, Kram, David E., primary, Snuderl, Matija, primary, Bridges, Leslie, primary, Martin, Andrew J., primary, Doey, Lawrence J., primary, Al-Sarraj, Safa, primary, Chandler, Christopher, primary, Zebian, Bassel, primary, Cairns, Claire, primary, Natrajan, Rachael, primary, Boult, Jessica K.R., primary, Robinson, Simon P., primary, Sill, Martin, primary, Dunkel, Ira J., primary, Gilheeney, Stephen W., primary, Rosenblum, Marc K., primary, Hughes, Debbie, primary, Proszek, Paula Z., primary, Macdonald, Tobey J., primary, Preusser, Matthias, primary, Haberler, Christine, primary, Slavc, Irene, primary, Packer, Roger, primary, Ng, Ho-Keung, primary, Caspi, Shani, primary, Popović, Mara, primary, Faganel Kotnik, Barbara, primary, Wood, Matthew D., primary, Baird, Lissa, primary, Davare, Monika Ashok, primary, Solomon, David A., primary, Olsen, Thale Kristin, primary, Brandal, Petter, primary, Farrell, Michael, primary, Cryan, Jane B., primary, Capra, Michael, primary, Karremann, Michael, primary, Schittenhelm, Jens, primary, Schuhmann, Martin U., primary, Ebinger, Martin, primary, Dinjens, Winand N.M., primary, Kerl, Kornelius, primary, Hettmer, Simone, primary, Pietsch, Torsten, primary, Andreiuolo, Felipe, primary, Driever, Pablo Hernáiz, primary, Korshunov, Andrey, primary, Hiddingh, Lotte, primary, Worst, Barbara C., primary, Sturm, Dominik, primary, Zuckermann, Marc, primary, Witt, Olaf, primary, Bloom, Tabitha, primary, Mitchell, Clare, primary, Miele, Evelina, primary, Colafati, Giovanna Stefania, primary, Diomedi-Camassei, Francesca, primary, Bailey, Simon, primary, Moore, Andrew S., primary, Hassall, Timothy E.G., primary, Lowis, Stephen P., primary, Tsoli, Maria, primary, Cowley, Mark J., primary, Ziegler, David S., primary, Karajannis, Matthias A., primary, Aquilina, Kristian, primary, Hargrave, Darren R., primary, Carceller, Fernando, primary, Marshall, Lynley V., primary, von Deimling, Andreas, primary, Kramm, Christof M., primary, Pfister, Stefan M., primary, Sahm, Felix, primary, Baker, Suzanne J., primary, Mastronuzzi, Angela, primary, Carai, Andrea, primary, Vinci, Maria, primary, Capper, David, primary, Popov, Sergey, primary, Ellison, David W., primary, Jacques, Thomas S., primary, Jones, David T.W., primary, and Jones, Chris, primary
- Published
- 2023
- Full Text
- View/download PDF
46. Mismatch repair–deficient glioma with spatially distinct IDH-mutant and IDH-wild type components arising in the setting of Lynch syndrome
- Author
-
Tan, Hao, primary, Nerison, Caleb, additional, Stateler, Cooper, additional, Bowden, Stephen G., additional, Raslan, Ahmed M., additional, Ambady, Prakash, additional, Barajas, Ramon F., additional, and Wood, Matthew D., additional
- Published
- 2023
- Full Text
- View/download PDF
47. Loss of Gata1 decreased eosinophils, macrophages, and type 2 cytokines in regenerating nerve and delayed axon regeneration after a segmental nerve injury
- Author
-
Liebendorfer, Adam, primary, Finnan, Michael J., additional, Schofield, Jonathon Blake, additional, Pinni, Sai L., additional, Acevedo-Cintrón, Jesús A., additional, Schellhardt, Lauren, additional, Snyder-Warwick, Alison K., additional, Mackinnon, Susan E., additional, and Wood, Matthew D., additional
- Published
- 2023
- Full Text
- View/download PDF
48. Video-based Learning in Surgery: Establishing Surgeon Engagement and Utilization of Variable-duration Videos
- Author
-
Yee, Andrew, Padovano, William M., Fox, Ida K., Hill, Elspeth J. R., Rowe, Amanda G., Brunt, L. Michael, Moore, Amy M., Snyder-Warwick, Alison K., Kahn, Lorna C., Wood, Matthew D., Coert, Jan Henk, and Mackinnon, Susan E.
- Published
- 2020
- Full Text
- View/download PDF
49. Decision Making in a Convergent Society
- Author
-
Linkov, Igor, Gisladottir, Viktoria, Wood, Matthew D., Bainbridge, William Sims, editor, and Roco, Mihail C., editor
- Published
- 2016
- Full Text
- View/download PDF
50. Enhanced efficiency urea fertilizers and timing effects on N2O emissions from spring wheat production in Manitoba
- Author
-
Wood, Matthew D., Gao, Xiaopeng, Tiessen, Kevin H. D., Tenuta, Mario, and Flaten, Donald N.
- Abstract
Opportunities exist to reduce nitrous oxide (N2O) emissions from nitrogen (N) fertilizers using enhanced efficiency fertilizers (EEFs) and managing application timing. This study examined (1) application timing (fall/spring) and (2) fertilizer N source on N2O emissions, yield, and N uptake of Canadian hard red spring wheat (Triticum aestivumL.) in Southern Manitoba. Fertilizer N sources included granular urea and four EEF products: (1) polymer‐coated urea (environmentally smart nitrogen [ESN]); (2) urea plus nitrification inhibitor (eNtrench); (3) urea plus urease inhibitor (Limus); and (4) urea plus nitrification and urease inhibitor (SuperU). Nitrification‐inhibited products most consistently reduced N2O emissions while maintaining productivity. Compared to urea alone, urea + eNtrench was most effective in reducing cumulative N2O emissions by 47%–64% at four of six site‐years. SuperU reduced N2O emissions by 37%–57% at three of six site‐years. ESN and urea + Limus did not affect emissions in most years. Wheat yield, protein, and N uptake were unaffected by N source in five of six site‐years. Compared to spring, fall application gave greater N2O emissions by 33%–67% at three of six site‐years due to spring‐thaw emissions. Fall was inferior to spring application in wetter site years with lower yield, protein, and N uptake. Overall, nitrification‐inhibited products—either alone or with a urease inhibitor—are a promising tool to reduce N2O emissions while maintaining wheat productivity in Manitoba. However, given that there were few consistent increases in yield or protein, the additional cost of the inhibitors will be a barrier to adoption. EEF products with nitrification and nitrification/urease inhibitors consistently reduced N2O emissions.Controlled release urea and urease‐inhibited urea did not reduce N2O emissions.Fall application of urea increased N2O emissions in three site‐years compared to spring application.The nitrification inhibitors applied with urea in fall or spring were effective to reduce N2O emissions.Overall, fall application decreased yield, grain protein, and N uptake in relatively wet years.
- Published
- 2024
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.